Haemanthus, the Austin startup run by Billy Evans, partner of convicted Theranos founder Elizabeth Holmes, has reportedly raised as much as $20 million and holds a granted patent, but has yet to launch a commercial product or publish independently validated results.
Billy Evans’ Haemanthus raises up to $20 million without a product on sale
Haemanthus, the Austin startup run by Billy Evans, partner of convicted Theranos founder Elizabeth Holmes, has reportedly raised as much as $20 million and holds a granted patent, but has yet to launch a commercial product or publish independently validated results.
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.